by Lisa Willemse | Jun 29, 2012
With contributions from Michael Rudnicki. If you’re following recent announcements in the field, then you may know about the study published this week in Diabetes that details the use of human embryonic stem cells (hESCs) to reverse diabetes type 1 in a mouse...
by Paul Krzyzanowski | May 22, 2012
Many readers may already have heard of Health Canada’s approval of Osiris’ Prochymal, a mesenchymal stem cell treatment for severe cases of pediatric Graft versus Host Disease (GvHD), with plenty of coverage circulating around the web. GvHD is a disease where...
by Ubaka Ogbogu | May 18, 2012
The Federal Government has proposed amendments to the Assisted Human Reproduction Act, the legislation that governs embryo research, including many aspects of stem cell research. The amendments, which are contained in an omnibus budget implementation bill tabled...
by Stem Cell Network | May 16, 2012
Welcome to Signals Blog, the new home and new name for the Stem Cell Network Blog. Why the change? After nearly four years, 207 blog posts and several “best of” awards, the SCN Blog finally outgrew its dish, so to speak. Late last year, we began planning...
by Stem Cell Network | May 11, 2012
By all accounts, the 35 entries in this year’s Cells I See Art Contest & Gallery Showing were among the best we’ve ever had. Certainly, there were more than we’d ever seen before (view them all here) — so many, in fact, that we had...
by Angela C. H. McDonald | Apr 17, 2012
Most research on stem cells involves the manipulation of gene expression, to some degree or another. During stem cell differentiation, the expression of specific genes orchestrates the choices cells make along the path from stem cell to adult cell — a process...
Comments